Components of the fibrinolytic system, such as plasminogen activators and inhibitors, are frequently overexpressed in aggressive cancers and serve as biomarkers of poor prognosis [44,202], and fibrin itself acts as a scaffold for tumor cells, providing structural support for cell migration and tumor growth [53,136,137,138,139,141,142,145]. This evidence concerns the gene PLG and neoplasm.